Although clinical and epidemiologic studies have linked diabetes with increased HNSCC incidence and poorer prognoses, the specific connection between insulin signaling and glucose-fueled redox metabolism in HNSCC remains largely unexplored (49–51). The gene discussed is INS; the disease is head and neck squamous cell carcinoma.